Kevin Chu
Principal at F-Prime Capital
San Francisco, California
Overview
Work Experience
Principal
2014 - Current
Invest venture capital in private biopharmaceutical, medical technology, and healthcare IT and services companies Senior Associate: 2019 - 2020 Associate: 2017 - 2019 Analyst: 2014 - 2016
F-Prime Capital is a venture capital firm investing in healthcare and technology.
Head of Enterprise Business Development
2020 - 2022
Collaboration between the Broad Institute, F-Prime, and GV that aims to increase the capacity, availability, accessibility, and affordability of COVID-19 testing
Project Beacon COVID-19 is a social benefit organization helping to increase the availability, and accessibility of COVID-19 testing.
Associate Consultant
2011 - 2014
Advised pharmaceutical and biotech clients on business issues relating to pricing, market access, and commercial strategy for their late stage development or commercial stage assets Analyst: 2011 - 2013
IMS Health provides information, services and technology for the pharmaceutical and healthcare industry.
Raised $1,289,750,000.00.
Summer Analyst
2010 - 2010
Performed technology due diligence and developed portfolio management tools to streamline deal flow for members
Business Research Consultant
2010 - 2010
Developed market segmentation strategies for small business clients through landscape and competitive research
Analyst
2009 - 2009
Conducted research on trending local start-ups across the software, IT, and healthcare industries
Education
BSE
2007 - 2011